FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "OSRX, Inc.(117108300)" | 83826-9014 | 83826-9014-5 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | 83826-9016 | 83826-9016-8 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9011 | 83826-9011-3 | Atropine Sulfate | .25 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9010 | 83826-9010-3 | Atropine Sulfate | .1 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9012 | 83826-9012-3 | Atropine Sulfate | .5 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | Atropine Sulfate | .1 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Atropine Sulfate | .25 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Atropine Sulfate | .5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | 83826-9057 | 83826-9057-2 | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | 83826-9055 | 83826-9055-4 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 10 mg/1 mL; .75 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9055 | 83826-9055-5 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 10 mg/1 mL; .75 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | Prednisolone Sodium Phosphate; Bromfenac Sodium | 10 mg/1 mL; .75 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Prednisolone Sodium Phosphate; Bromfenac Sodium | 10 mg/1 mL; .75 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Prednisolone Sodium Phosphate; Ketorolac Tromethamine | 10 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Prednisolone Sodium Phosphate; Ketorolac Tromethamine | 10 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | 83826-9033 | 83826-9033-5 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 10 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 10 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 10 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | 83826-9006 | 83826-9006-5 | Timolol Maleate; Brimonidine Tartrate; Dorzolamide Hydrochloride | 5 mg/1 mL; 1 mg/1 mL; 20 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | Timolol Maleate; Brimonidine Tartrate; Dorzolamide Hydrochloride | 5 mg/1 mL; 1 mg/1 mL; 20 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | 83826-9018 | 83826-9018-5 | Bimatoprost; Timolol Maleate | .1 mg/1 mL; 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | Bimatoprost; Timolol Maleate | .1 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Bimatoprost; Timolol Maleate; Brimonidine Tartrate; Dorzolamide Hydrochloride | .1 mg/1 mL; 5 mg/1 mL; 1 mg/1 mL; 20 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | 83826-9003 | 83826-9003-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate | .1 mg/1 mL; 5 mg/1 mL; 20 mg/1 mL; 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | Bromfenac Sodium; Brimonidine Tartrate | .75 mg/1 mL; 1 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Bromfenac Sodium; Brimonidine Tartrate | .75 mg/1 mL; 1 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Dorzolamide Hydrochloride; Brimonidine Tartrate | 20 mg/1 mL; 1 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Dorzolamide Hydrochloride; Brimonidine Tartrate | 20 mg/1 mL; 2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | 83826-9059 | 83826-9059-2 | Dorzolamide Hydrochloride; Brimonidine Tartrate | 20 mg/1 mL; 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | Dorzolamide Hydrochloride; Brimonidine Tartrate | 20 mg/1 mL; 2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide | 5 mg/1 mL; 100 mg/1 mL; 10 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Neostigmine | 3000 mg/3000 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Neostigmine | 5 mg/5 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 3 g/3 L | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 22500 U/2250 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 15000 U/1500 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 22500 U/2250 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 20 U/1000 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 20 U/1000 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30 U/500 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30 U/500 mL | 2023-2 | source_no_ndc | 2026-11-08 |